Abstract MP9-04: Preclinical and clinical examination of tissue-engineered graft for urethral reconstruction (MukoCell®) with regard to its safety
The quality and pre-clinical data of our lead product MukoCell have been certified by the European Medicines Agency (EMA).
MukoCell GmbH is particapting at 66th German Congress of Urology which will take place from October 1 to October 4, 2014, in Düsseldorf on the Rhine.
MukoCell GmbH is particapting at the 29. Annual EAU Congress from April 11th – 15th 2014
The MukoCell GmbH is particapting at the EuroMedtech 2013 , 07-08 May 2013, in Dusseldorf, Germany .
MukoCell GmbH has received authorisation to distribute its product MukoCell® pursuant to Section 4b of the Medicinal Products Act (AMG) – „Special provisions governing advanced therapy medicinal products“.
In the article „Business creation in Germany / A slow climb – A vigorous start-up scene has yet to produce its first big breakthrough“ published in The Economist from 5th October 2013, the MukoCell GmbH gets mentioned as one of Germanys promising Start-up companies in the field of Bioengineering.
Tissue-engineering can help to overcome problems, associated with tissue limitations for urological reconstruction.
A live surgery about urethral reconstruction with MukoCell will be performed by Dr. Dahlem, UKE Hamburg between 1 p.m. and 3 p.m. on the 10th of October 2013